Results 11 to 20 of about 2,772,421 (294)

Surgery for drug-resistant focal epilepsy

Annals of Indian Academy of Neurology, 2014
During the colloquium on drug-resistant epilepsy (DRE) at National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore on August 16-18, 2013, a number of presentations were made on the surgically remediable lesional epilepsy syndromes ...
Malla Bhaskara Rao, Arimappamagan Arivazhagan, Sanjib Sinha, Rose Dawn Bharath, Anita Mahadevan, Maya Bhat, Parthasarthy Satishchandra   +6 more
doaj   +4 more sources

Pathogenesis of drug resistant epilepsy [PDF]

Эпилепсия и пароксизмальные состояния, 2019
Pharmacotherapy is the first-line treatment modality for epilepsy. However, in 20-40% of patients, epilepsy is resistant to pharmacotherapy. These numbers have not changed for decades despite the development and use of antiepileptic drugs with novel ...
S. M. Malyshev, T. M. Alekseeva, W. A. Khachatryan, M. M. Galagudza   +3 more
doaj   +2 more sources

Clobazam as an Add-on Therapy of Patients with Drug-resistant Epilepsy: Experience of a Tertiary Epilepsy Center

Archives of Epilepsy, 2020
Objectives:This retrospective study aimed to overview the efficacy and side effects of clobazam in patients with drug-resistant epilepsy who were followed in a tertiary epilepsy center.Methods:The patients who had been started clobazam as add-on therapy ...
Nermin Görkem ŞİRİN, Betül BAYKAN, Nerses BEBEK   +2 more
doaj   +2 more sources

Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation

Epilepsia Open, 2022
More than one‐third of people with epilepsy develop drug‐resistant epilepsy (DRE). Different hypotheses have been proposed to explain the origin of DRE. Accumulating evidence suggests the contribution of neuroinflammation, modifications in the integrity ...
Patricia Campos‐Bedolla, Iris Feria‐Romero, Sandra Orozco‐Suárez   +2 more
doaj   +3 more sources

Epidemiology of drug resistant epilepsy in adults

Бюллетень сибирской медицины, 2018
This review examines the epidemiology of drug resistant epilepsy in adults in Russia and abroad. References were taken from Russian and foreign databases for the period from 2010–2017. Only full-text publications (66) were included in this review.
E. A. Narodova, N. A. Shnayder, S. V. Prokopenko, V. V. Narodova, A. A. Narodov, D. V. Dmitrenko   +5 more
doaj   +2 more sources

Responsive neurostimulation for treatment of pediatric drug-resistant epilepsy [PDF]

Epilepsy and Behavior Case Reports, 2018
Responsive neurostimulation for epilepsy involves an implanted device that delivers direct electrical brain stimulation in response to detection of incipient seizures.
Nilika S. Singhal, Adam L. Numis, Morgan B. Lee, Edward F. Chang, Joseph E. Sullivan, Kurtis I. Auguste, Vikram R. Rao   +6 more
doaj   +2 more sources

Factors associated with drug-resistant epilepsy in adults from Southern Kazakhstan. [PDF]

Future Sci OA
Introduction The prevalence of drug-resistant epilepsy (DRE) among epilepsy patients has not decreased despite better diagnostic methods and treatment options because it affects approximately one-third of all epilepsy patients.
Baimakhanova G, Nurdinov N, Nuskabayeva G, Zharkinbekova N, Sadykova K, Skenderova A, Gencer MZ, Doszhanov I, Yerkhojayeva N, Anarbayeva A, Skenderova S, Kaldarkhan D.   +11 more
europepmc   +2 more sources

A guide to neuromodulation in drug-resistant epilepsy. [PDF]

Epileptic Disord
Abstract Neuromodulation is approved for the treatment of drug‐resistant epilepsy. It has been increasingly utilized over the past two decades with the approval of deep brain stimulation (DBS) and responsive neurostimulation (RNS) in addition to vagus nerve stimulation (VNS)—particularly in patients who are not deemed to be good ...
Parikh P, Dolezawa I, Hegde M, Imbach L, Lundstrom BN, Pizzo F, Rao VR, Singh J, Southwell D, Watanabe S, Frauscher B.   +10 more
europepmc   +4 more sources

Twenty‐five years of epilepsy surgery at a Central European comprehensive epilepsy center—Trends in intervention delay and outcomes

Epilepsia Open, 2023
Objective We analyzed trends in patients' characteristics, outcomes, and waiting times over the last 25 years at our epilepsy surgery center situated in Central Europe to highlight possible areas of improvement in our care for patients with drug ...
Vít Všianský, Milan Brázdil, Ivan Rektor, Irena Doležalová, Jitka Kočvarová, Ondřej Strýček, Jan Hemza, Jan Chrastina, Eva Brichtová, Ondřej Horák, Patrícia Mužlayová, Markéta Hermanová, Michal Hendrych, Martin Pail   +13 more
doaj   +1 more source

Introduction to the special issue “Redesigning the hypotheses for drug‐resistant epilepsy”

Epilepsia Open, 2022
Drug‐resistant epilepsy represents an important neurological condition. Its prevalence is not modified in spite of the different hypotheses established to understand the mechanisms involved.
Luisa Rocha
doaj   +1 more source